- Home
- WASH vs CELC Comparison
WASH vs CELC Comparison
Compare WASH & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WASH
- CELC
- Stock Information
- Founded
- WASH 1800
- CELC 2011
- Country
- WASH United States
- CELC United States
- Employees
- WASH N/A
- CELC N/A
- Industry
- WASH Major Banks
- CELC Medical Specialities
- Sector
- WASH Finance
- CELC Health Care
- Exchange
- WASH Nasdaq
- CELC Nasdaq
- Market Cap
- WASH 540.4M
- CELC 440.0M
- IPO Year
- WASH N/A
- CELC 2017
- Fundamental
- Price
- WASH $30.33
- CELC $51.63
- Analyst Decision
- WASH Buy
- CELC Strong Buy
- Analyst Count
- WASH 4
- CELC 5
- Target Price
- WASH $32.25
- CELC $53.60
- AVG Volume (30 Days)
- WASH 122.7K
- CELC 1.1M
- Earning Date
- WASH 10-20-2025
- CELC 08-14-2025
- Dividend Yield
- WASH 7.39%
- CELC N/A
- EPS Growth
- WASH N/A
- CELC N/A
- EPS
- WASH N/A
- CELC N/A
- Revenue
- WASH $116,006,000.00
- CELC N/A
- Revenue This Year
- WASH $57.40
- CELC N/A
- Revenue Next Year
- WASH $9.62
- CELC N/A
- P/E Ratio
- WASH N/A
- CELC N/A
- Revenue Growth
- WASH N/A
- CELC N/A
- 52 Week Low
- WASH $24.95
- CELC $7.58
- 52 Week High
- WASH $40.59
- CELC $55.44
- Technical
- Relative Strength Index (RSI)
- WASH 64.73
- CELC 76.90
- Support Level
- WASH $27.98
- CELC $48.73
- Resistance Level
- WASH $30.96
- CELC $55.44
- Average True Range (ATR)
- WASH 0.71
- CELC 2.65
- MACD
- WASH 0.25
- CELC -0.78
- Stochastic Oscillator
- WASH 81.25
- CELC 88.28
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.